Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1990 1
1992 1
1994 2
1995 4
1996 4
1997 2
1998 1
1999 4
2000 7
2001 1
2002 5
2003 7
2004 16
2005 16
2006 12
2007 5
2008 9
2009 10
2010 10
2011 6
2012 9
2013 11
2014 4
2015 8
2016 12
2017 8
2018 6
2019 8
2020 6
2021 7
2022 2
2023 3
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma.
Chaturantabut S, Oliver S, Frederick DT, Kim J, Robinson FP, Sinopoli A, Song TY, Rodriguez DJ, Chang L, Kesar D, He Y, Ching M, Dzvurumi R, Atari A, Tseng YY, Bardeesy N, Sellers WR. Chaturantabut S, et al. Among authors: sellers wr. bioRxiv [Preprint]. 2024 Sep 18:2024.09.16.613045. doi: 10.1101/2024.09.16.613045. bioRxiv. 2024. PMID: 39345400 Free PMC article. Preprint.
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets.
Vijay V, Karisani N, Shi L, Hung YH, Vu P, Kattel P, Kenney L, Merritt J, Adil R, Wu Q, Zhen Y, Morris R, Kreuzer J, Kathiresan M, Herrera Lopez XI, Ellis H, Gritti I, Lecorgne L, Farag I, Popa A, Shen W, Kato H, Xu Q, Balasooriya ER, Wu MJ, Chaturantabut S, Kelley RK, Cleary JM, Lawrence MS, Root D, Benes CH, Deshpande V, Juric D, Sellers WR, Ferrone CR, Haas W, Vazquez F, Getz G, Bardeesy N. Vijay V, et al. Among authors: sellers wr. bioRxiv [Preprint]. 2024 Jul 8:2024.07.04.601970. doi: 10.1101/2024.07.04.601970. bioRxiv. 2024. PMID: 39026794 Free PMC article. Preprint.
A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression.
Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR. Majumder PK, et al. Among authors: sellers wr. Cancer Cell. 2024 Jun 10;42(6):1126. doi: 10.1016/j.ccell.2024.05.008. Epub 2024 May 30. Cancer Cell. 2024. PMID: 38866454 No abstract available.
The next big questions in cancer research.
Loi S, Settleman J, Joyce JA, Pramesh CS, Bernards R, Fan J, Merchant JL, Moslehi J, Sellers WR. Loi S, et al. Among authors: sellers wr. Cell. 2023 Apr 13;186(8):1523-1527. doi: 10.1016/j.cell.2023.01.037. Cell. 2023. PMID: 37059060 Free article.
Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors.
Tiedt R, King FJ, Stamm C, Niederst MJ, Delach S, Zumstein-Mecker S, Meltzer J, Mulford IJ, Labrot E, Engstler BS, Baltschukat S, Kerr G, Golji J, Wyss D, Schnell C, Ainscow E, Engelman JA, Sellers WR, Barretina J, Caponigro G, Porta DG. Tiedt R, et al. Among authors: sellers wr. Cell Rep. 2023 Apr 25;42(4):112297. doi: 10.1016/j.celrep.2023.112297. Epub 2023 Mar 23. Cell Rep. 2023. PMID: 36961816 Free article.
208 results